Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
DANIEL D VONHOFF
Listed Specialty: Hematology & Oncology
13400 E SHEA BLVD, SCOTTSDALE, AZ, 85259-5404
DR. DANIEL VONHOFF,
Yearly Payment Breakdown:
2018 Payments At a Glance
20
payments
$28,752
payment total
5
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
5 | $25,089 |
Travel and Lodging |
8 | $2,828 |
Food and Beverage |
7 | $836 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
KINERET |
drug |
$19,698 |
RF 3000 |
device |
$4,456 |
NON-COVERED PRODUCT |
drug |
$2,259 |
ONIVYDE |
drug |
$1,613 |
THERAPIES |
device |
$619 |
ONCOLOGY |
device |
$108 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Apr 20, 2018 | $8,680 | KINERET | Consulting | SWEDISH ORPHAN BIOVITRUM AB | |
| Apr 20, 2018 | $8,680 | KINERET | Consulting | SWEDISH ORPHAN BIOVITRUM AB | |
| Nov 6, 2018 | $4,000 | RF 3000 | Consulting | BOSTON SCIENTIFIC CORPORATION | NDA CONSULTING CORP |
| Mar 31, 2018 | $2,259 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 1, 2018 | $1,470 | ONIVYDE | Consulting | IPSEN BIOPHARMACEUTICALS, INC | |
| Apr 20, 2018 | $834 | KINERET | Travel and Lodging | SWEDISH ORPHAN BIOVITRUM AB | |
| Apr 20, 2018 | $744 | KINERET | Travel and Lodging | SWEDISH ORPHAN BIOVITRUM AB | |
| Apr 19, 2018 | $342 | KINERET | Travel and Lodging | SWEDISH ORPHAN BIOVITRUM AB | |
| Nov 14, 2018 | $333 | RF 3000 | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | NDA CONSULTING CORP |
| Oct 15, 2018 | $318 | THERAPIES | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | |
| Oct 16, 2018 | $274 | THERAPIES | Food and Beverage | BOSTON SCIENTIFIC CORPORATION | |
| Apr 20, 2018 | $195 | KINERET | Food and Beverage | SWEDISH ORPHAN BIOVITRUM AB | |
| Apr 20, 2018 | $132 | KINERET | Travel and Lodging | SWEDISH ORPHAN BIOVITRUM AB | |
| Jun 1, 2018 | $125 | ONIVYDE | Food and Beverage | IPSEN BIOPHARMACEUTICALS, INC | |
| Jun 5, 2018 | $108 | ONCOLOGY | Food and Beverage | NOVOCURE INC. | |
| Nov 14, 2018 | $98 | RF 3000 | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | NDA CONSULTING CORP |
| Apr 20, 2018 | $91 | KINERET | Food and Beverage | SWEDISH ORPHAN BIOVITRUM AB | |
| Oct 16, 2018 | $27 | THERAPIES | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | |
| Nov 14, 2018 | $25 | RF 3000 | Food and Beverage | BOSTON SCIENTIFIC CORPORATION | NDA CONSULTING CORP |
| Jun 1, 2018 | $19 | ONIVYDE | Food and Beverage | IPSEN BIOPHARMACEUTICALS, INC |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.